Methcathinone: a Russian designer amphetamine infiltrates the rural midwest
by Emerson TS, Cisek JE Department of Emergency Medicine, Marquette General Hospital, Michigan. Ann Emerg Med 1993 Dec; 22(12):1897-903
Four cases of methcathinone toxicity in the United States are presented and discussed. This drug is the latest in a series of “designer” amphetamines. Prominent findings of acute toxicity include hallucinations, fever, and tachycardia followed by periods of bradycardia and moderate hypotension as acute symptoms resolve. Chronic binge use may result in development of paranoid psychosis and brief periods of withdrawal tremors. Our current understanding of methcathinone effects and the Russian experience with it are discussed. Our recommendations for treatment of acute toxicity are based on well established guidelines for managing the toxicity of similar amphetamine-like drugs.
For those seeking addiction treatment for themselves or a loved one, the Amphetamines.com helpline is a private and convenient solution.
Calls to any general helpline (non-facility specific 1-8XX numbers) for your visit will be answered by American Addiction Centers (AAC), a paid advertiser on Amphetamines.com.
AAC representatives are standing by 24/7 to discuss your treatment options. These representatives work solely for AAC and will discuss whether an AAC facility may be an option for you. This helpline is offered at no cost to you and with no obligation to enter into treatment. Neither Amphetamines.com nor AAC receives any commission or other fee that is dependent upon which treatment provider a visitor may ultimately choose.
For more information on AAC’s commitment to ethical marketing and treatment practices, or to learn more about how to select a treatment provider, visit AmericanAddictionCenters.org. If you wish to explore additional treatment options or connect with a specific rehab center, you can browse top-rated listings or visit SAMHSA.